Charles st-Pierre

Charles St-Pierre, PhD, is a Medical Advisor specializing in Respiratory and Rheumatology at AstraZeneca since December 2018, contributing to the strategic and operational development of the Fasenra (Benralizumab) brand. St-Pierre has held various roles within AstraZeneca, including Global Medical Affairs Lead for Emerging Medicines in Immunology Cell Therapy and Medical Science Liaison, where responsibilities involved scientific training, stakeholder engagement, and supporting clinical trials. Prior experience includes research scientist positions at CellCarta and Citoxlab, focusing on immunology and oncology, along with a strong educational background that includes a PhD in Molecular Biology from Université de Montréal.